| Infertility Female |
0 |
0.9 |
| Rheumatic Disease |
0 |
1 |
| Pregnancy |
0 |
0.45 |
| Systemic Lupus Erythematosus |
0 |
0.43 |
| Assisted Reproductive Technology |
0 |
0.99 |
| Reproduction Technology |
0 |
0.98 |
| Reproductive Health |
0 |
0.28 |
| Hospital |
0 |
0.23 |
| Revenue and Practice Management |
0 |
0.22 |
| Clinical Guidelines |
0 |
0.19 |
| Estrogen |
0 |
0.19 |
| Fellowship |
0 |
0.14 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.14 |
| Infertility |
0 |
0.14 |
| New York |
0 |
0.14 |
| Thromboembolism |
0 |
0.13 |
| Private Practice |
0 |
0.09 |
| Surgery |
0 |
0.09 |
| Ultrasonography |
0 |
0.09 |
| Anticoagulation Therapy |
0 |
0.05 |
| Antiphospholipid Syndrome |
0 |
0.05 |
| Aromatase Inhibitors |
0 |
0.05 |
| Attending Physician |
0 |
0.05 |
| Cancer |
0 |
0.05 |
| Capillary |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Cytokines |
0 |
0.05 |
| Hormonal Therapy |
0 |
0.05 |
| In Vitro Fertilization |
0 |
0.05 |
| Low-Molecular-Weight Heparin |
0 |
0.05 |
| Lupus |
0 |
0.05 |
| Ovarian Hyperstimulation Syndrome |
0 |
0.05 |
| Preeclampsia |
0 |
0.05 |
| Rhode Island |
0 |
0.05 |
| Sedative |
0 |
0.05 |
| Deep Venous Thrombosis |
0 |
0.04 |
| Healthcare and Medical Technology |
0 |
0.04 |
| Hypertension |
0 |
0.04 |
| Renal Failure |
0 |
0.04 |